Market Analysis: Global Interventional Oncology Devices Market

Global Interventional Oncology Devices Market is expected to rise from its initial estimated value of USD 1.99 billion to an estimated value of USD 3.28 billion by 2026, registering a CAGR of 6.45% in the forecast period of 2019-2026. Increasing patient preference for minimally invasive procedures is the major factor for the growth of this market.

Few of the major competitors currently working in the interventional oncology devices market are BTG International Ltd., Medtronic, Boston Scientific Corporation, Terumo Medical Corporation, Merit Medical Systems,  Sirtex Medical, AngioDynamics, Ethicon USA, LLC., Teleflex Incorporated, Cook Medical Incorporated, HealthTronics, Inc., MedWaves, Inc., IMBIOTECHNOLOGIES LTD., Trod Medical, ICECURE MEDICAL, INterface BIOmaterials B.V.

Get Sample Analysis of Global Market Information: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-interventional-oncology-devices-market

Market Definition: Global Interventional Oncology Devices Market

Oncology deals with the treatment, prevention and diagnosis of cancer. Oncologist is the physician who works in field o oncology. Biopsy, endoscopy, X-ray, CT scanning, MRI, PET scanning, ultrasound or other radiological methods are used to diagnose cancer. Interventional technology is a type of cancer care which is done with minimally invasive procedure and reduce the risk of infection, minimal complications, shorter hospital stay, lesser pain, and faster recovery time as compared to the conventional open surgeries,

Market Drivers

Increasing government support for the interventional oncology is driving the market.
Technological advancement in the oncology devices.

Market Restraints

Lack of professionals and skilled radiologists and oncologists is restraining the growth of this market.
Strict regulations are restraining the market.
Segmentation: Global Interventional Oncology Devices Market
By Product
Embolization Devices
Ablation Devices
Support Devices
By Procedure
Thermal Tumor Ablation
Non-Thermal Tumor Ablation
Transcatheter Arterial Chemoembolization
Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
Transcatheter Arterial Embolization/Bland Embolization
By Cancer
 Liver Cancer
 Lung Cancer
 Bone Cancer
 Kidney Cancer
By Geography
North America
US.
Canada
Mexico
South America
Brazil
Argentina
Rest of South America
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Turkey
Belgium
Netherlands
Switzerland
Rest of Europe
Asia-Pacific
Japan
China
South Korea
India
Australia
Singapore
Thailand
Malaysia
Indonesia
Philippines
Rest of Asia Pacific
Middle East & Africa
South Africa
Egypt
Saudi Arabia
United Arab Emirates
Israel
Rest of Middle East & Africa

Get TOC of Full Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-interventional-oncology-devices-market

Key Developments in the Market:

In April 2016, Oncology Services International announced the launch of their new remote connection capability, OSI Onsite which will give remote access for troubleshooting, predictive failure analysis and preventive maintenance. OSI OnSite utilizes state-of-the-art technology and cloud-based resources, minimizing invasive installation processes and updates and meets all healthcare requirements.
In April 2018, Varian announced the launch of their new version of Velocity cancer imaging software which includes Rapidsphere, a module for Y90 Selective Internal Radiation Therapy (SIRT) dosimetry analysis. It helps in understanding the tumor better and normal- tumor toxicity of individual patient.

Competitive Analysis:

Global interventional oncology devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of interventional oncology devices market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.